-
FDA accepts listing application for oberic acid treatment for non-alcoholic fatty hepatitis
Time of Update: 2020-06-07
recently, Intercept announced The FDA (http:// has accepted a market ingressation application for the treatment of non-alcoholic fatty hepatitis (NASH) for liver fibrosis and has been qualified f
-
First Three Exits U.S. Pain Management Market
Time of Update: 2020-06-01
Sunao Manabe, the new chief executive of first-three, said on a conference call that the company had returned Movantik, a treatment drug for opioid-induced constipation, to AstraZeneca from October an
-
Mercadon Anaesthetic Awakening Period Muscle Loose Antagonist Rookie - Shu's Sweet
Time of Update: 2020-05-31
Sugammadex sodium is the first selective antagonist developed by Mercado Pharmaceuticals First listed in Sweden in 2008, it was used to reverse muscle relaxation symptoms caused by aloof ammonium or v
-
The first review of the micropharmaceutical hydro bromochloric right meschafin tablets
Time of Update: 2020-05-31
Hydro bromonate right meschafin tablets for the cough type of over-the-counter drugs, belong to class A over-the-counter drugs, suitable for dry cough, including upper respiratory tract infections (su
-
What about K-drug sales of more than $10 billion PD-(L)1 drug sales in 2019
Time of Update: 2020-05-30
To date, a total of 10 PD-(L)1 cancer immunotherapy drugs have been available worldwide, including four domestic and six multinational pharmaceutical companies: BMS's Opdivo, Mercado's Keytruda, AZ's
-
The field inspection of recombinant human follicle stimulating hormone for injection has been completed
Time of Update: 2020-04-03
CFDA website January 6 The information shows that the application status of recombinant human follicle stimulating hormone for injection of heavy biological products of Jinsai Pharmaceutical Co., Ltd.
-
Ruixing layout of medical device hemophilia gene therapy of "medical fast reading society" is qualified for priority evaluation
Time of Update: 2020-02-21
[February 21, 2020 / medical information list] Junsai biology announced the completion of pre-A round of financing; GSK invested heavily in the layout of new tcr-t cell therapy; hispec ciprofol emulsi
-
Bladder cancer "platinum free, targeted + immune" program! The combination of padcev + keytruda obtained the breakthrough drug qualification, and the total remission rate of first-line treatment
Time of Update: 2020-02-21
February 21, 2020 / BIOON / -- Seattle genetics and Astellas recently announced that the U.S Food and Drug Administration (FDA) has awarded the antibody drug conjugate (ADC) padcev (enfortumab) The co
-
Domestic anti BCMA car-t cell therapy! Keji biological ct053 has obtained the qualification of American FDA orphan drug to treat multiple myeloma
Time of Update: 2019-08-31
August 31, 2019 / BIOON / -- carsgen therapeutics (Shanghai) Co., Ltd (hereinafter referred to as "carsgen therapeutics") is a clinical stage immunooncology company, which is committed to the developm
-
Newsletter! Third quarter report of Huahai pharmaceutical: affected by valsartan incident, net profit decreased by 47.38% year on year, affecting or continuing, 5 litigation cases to be solved
Time of Update: 2018-11-01
On October 31, Huahai pharmaceutical released the third quarter report From January to September 2018, the revenue of Huahai pharmaceutical reached 3.843 billion yuan, an increase of 9.48% over the sa
-
[quick news] on June 21, 2018, 9 platforms for transformation of scientific and technological achievements of Chinese Academy of Sciences landed in Fujian
Time of Update: 2018-06-21
The signing ceremony of 9 CAS platforms for the transformation of scientific and technological achievements was held in Fuzhou Strait International Convention and Exhibition Center on June 19 9 CAS pl
-
Imfinzi, a new AstraZeneca immune drug, has been recognized as a breakthrough therapy for lung cancer
Time of Update: 2017-08-01
Source: AstraZeneca announced today that the FDA of the United States has granted the PD-L1 inhibitor imfinzi (duravulumab) breakthrough therapy to treat patients with locally advanced and non resecta
-
Nature weighs! Huaxi Hospital will carry out the world's first CRISPR human body test to declare war on lung cancer
Time of Update: 2016-07-22
Source: biological exploration July 21, 2016, according to the official website of nature, Chinese scientists will carry out the world's first CRISPR human test Professor Lu u, an oncologist at West C
-
Huahai Pharmaceutical's New Drug Valsartan Tablets Approved for Sale in the U.S
Time of Update: 2015-06-12
Source: on the evening of June 11, 2015, Huahai pharmaceutical announced in the securities times that the company had received a notice from the U.S Food and Drug Administration (FDA) that the company
-
FDA approved drugs for children 2009-2014
Time of Update: 2014-06-05
Source: Yiyao Mofang (wechat: Yiyao Mofang) released the "children's drug list that is expected to speed up the review", and I also combed the children's drugs approved by FDA in recent years from ano
